Last Updated 3 August 2021.
3 Vaccines Approved for Use in Japan
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
Approval Source: takeda.com
-
Pfizer/BioNTech
BNT162b2- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 97 countries
32 trials in 2 countries
Approval Source: japantimes.co.jp
-
Oxford/AstraZeneca
AZD1222- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 120 countries
35 trials in 3 countries
Approval Source: astrazeneca.com
9 Vaccines in Clinical Trials in Japan
-
AnGes
AG0302-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
4 trials in 1 country
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 59 countries
11 trials in 2 countries
-
Shionogi
S-268019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takeda
TAK-019 (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
AnGes
AG0301-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Daiichi Sankyo Co Ltd
DS-5670a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Elixirgen Therapeutics Inc
EXG-5003- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
KM Biologics Co Ltd
KD-414- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country